SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-24-000055
Filing Date
2024-07-11
Accepted
2024-07-11 08:15:44
Documents
13
Period of Report
2024-07-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K flks-20240709.htm   iXBRL 8-K 25534
  Complete submission text file 0001615219-24-000055.txt   150065

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240709.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240709_lab.xml EX-101.LAB 22592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240709_pre.xml EX-101.PRE 13078
15 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240709_htm.xml XML 2724
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 241111079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)